The World Health Organization has announced an outbreak of Ebola in the Democratic Republic of Congo and its continued investigation of almost 200 cases of unexplained acute hepatitis in the US and Europe in a media briefing Tuesday afternoon. Two cases of Ebola have been confirmed in the northwestern Democratic Republic of Congo, prompting health […] Continue reading ->
CAPE TOWN – A new partnership between African scientists and pharmaceutical company Johnson & Johnson (J&J), aimed at finding solutions to antimicrobial resistance (AMR), was launched in South Africa on Monday. The J&J Satellite Center for Global Health Discovery, housed at the University of Cape Town (UCT)’s Holistic Drug Discovery and Development (H3D) Center, will […] Continue reading ->
Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading ->
After Dr Garry Aslanyan became an avid follower of podcasts, he realized there was a dearth of material from the genre in his own global health field. So he set out to fill that gap with a new series featuring public health professionals and policymakers from around the world who have made a difference – […] Continue reading ->
The second season of the Global Health Matters podcast series kicks off with a close-up look at South Africa’s health equity initiatives and champions. Health Policy Watch will be featuring episodes from the series throughout the coming year as part of a TDR-supported series. As the world commits to equitable access to medicines and vaccines, […] Continue reading ->
Pfizer has so far refused an invitation from the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) to cooperate on a study exploring whether the treatment window of its successful antiviral drug, Paxlovid, could be extended from 5-7 days using another drug compound in addition, Dr Nathalie Strub-Wourgaft, Director of DNDi’s COVID-19 Response, told Health Policy […] Continue reading ->
TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading ->
In a highly symbolic visit to Lviv, Ukraine, World Health Organization Regional Director Hans Kluge reaffirmed WHO’s commitment to rebuilding the country’s war-torn health system. Speaking in a press briefing staged directly from Lviv, Kluge said, “We are committed to work through a decentralized footprint [in Ukraine], both during the current humanitarian response but also […] Continue reading ->
The World Health Organization (WHO) has confirmed 82 attacks on healthcare in Ukraine since 24 February. The country’s virtual healthcare services, already strong from the pandemic, have stepped-up in response. Why it matters Online healthcare has provided a crucial lifeline to thousands of Ukrainians as the war imposes physical and psychological trauma on those caught […] Continue reading ->
A compromise proposal on a World Trade Organisation’s (WTO) waiver on intellectual property for the production of COVID-19 vaccines is ‘problematic’, ‘largely insufficient’, and WTO members should not be politically pressured into adopting the text, several dozen civil society organisations said in an open letter published today. The letter, addressed to European Commissioners, European members […] Continue reading ->